Stock Fundamentals

Company Information

▼
Company Name
Immunovant Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45258J1025
CIK: 0001764013
CUSIP: 45258J201
Currency: USD
Full Time Employees: 362
Phone: 917 580 3099
Website: https://immunovant.com
Fiscal Year End: March
IPO Date: Jun 21, 2019
Description:

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and thyroid eye disease. The company was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Address:

320 West 37th Street, New York, NY, United States, 10018

Directors & Officers

▼
Name Title Year Born
Dr. Frank M. Torti M.B.A., M.D. Executive Chairperson of the Board 1979
Dr. Eric Venker M.D., Pharm.D. CEO & Director 1987
Ms. Melanie Gloria B.S.N. Chief Operating Officer 1979
Mr. Christopher A. Van Tuyl Esq., J.D. Chief Legal Officer & Corporate Secretary 1976
Mr. Tiago M. Girao CPA Chief Financial Officer 1979
Dr. Jay S. Stout M.S., Ph.D. Chief Technology Officer 1964
Ms. Christine Blodgett Senior Vice President of Human Resources NA
Dr. William L. Macias M.D., Ph.D. CMO Emeritus 1959
Mr. Andy Deig M.B.A. Senior Vice President of Strategic Finance NA
Ms. Julie Kirschling Senior Vice President of Program & Alliance Management NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
FMR Inc 16.99M Dec 31, 2025 8.35% $0.02 15.35%
Deep Track Capital, LP 9.73M Sep 30, 2025 4.78% $4.38 2.41%
Vanguard Group Inc 7.78M Dec 31, 2025 3.82% $0.00 13.95%
Armistice Capital, LLC 5.75M Dec 31, 2025 2.82% $1.74 -1.52%
BlackRock Inc 5.74M Sep 30, 2025 2.82% $0.00 -1.88%
Baker Bros Advisors LP 5.46M Dec 31, 2025 2.68% $0.81 0.00%
T. Rowe Price Investment Management,Inc. 5.16M Sep 30, 2025 2.54% $0.05 -24.92%
Point72 Asset Management, L.P. 3.44M Sep 30, 2025 1.69% $0.09 3.17%
RTW INVESTMENTS, LLC 3.18M Dec 31, 2025 1.56% $0.81 0.00%
State Street Corp 2.89M Sep 30, 2025 1.42% $0.00 2.21%
Two Seas Capital LP 2.76M Sep 30, 2025 1.36% $0.71 22.61%
Alpine Partners VI, LLC 2.75M Sep 30, 2025 1.35% $9.00 4.87%
ADAR1 Capital Management LLC 2.48M Dec 31, 2025 1.22% $4.63 10.67%
Woodline Partners LP 1.98M Dec 31, 2025 0.97% $0.19 31.84%
Morgan Stanley - Brokerage Accounts 1.96M Sep 30, 2025 0.96% $0.00 -15.16%
Geode Capital Management, LLC 1.80M Sep 30, 2025 0.89% $0.00 -1.31%
Perceptive Advisors LLC 1.59M Sep 30, 2025 0.78% $0.74 -25.73%
The Goldman Sachs Group Inc 1.48M Sep 30, 2025 0.73% $0.00 24.01%
Aberdeen Group PLC 1.18M Dec 31, 2025 0.58% $0.05 20.61%
Adage Capital Partners Gp LLC 863.00K Dec 31, 2025 0.42% $0.03 151.16%

Shares Statistics

▼
Shares Outstanding: 203.53M
Shares Float: 77.49M
% Insiders: 5,705.20%
% Institutions: 5,425.30%
Short % Float: 19.05%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 FMR Inc 16.99M 8.35% ▲ 15.35% Dec 31, 2025
2 Deep Track Capital, LP 9.73M 4.78% ▲ 2.41% Sep 30, 2025
3 Vanguard Group Inc 7.78M 3.82% ▲ 13.95% Dec 31, 2025
4 Armistice Capital, LLC 5.75M 2.82% ▼ 1.52% Dec 31, 2025
5 BlackRock Inc 5.74M 2.82% ▼ 1.88% Sep 30, 2025
6 Baker Bros Advisors LP 5.46M 2.68% ▲ 0.00% Dec 31, 2025
7 T. Rowe Price Investment Management,Inc. 5.16M 2.54% ▼ 24.92% Sep 30, 2025
8 Point72 Asset Management, L.P. 3.44M 1.69% ▲ 3.17% Sep 30, 2025
9 RTW INVESTMENTS, LLC 3.18M 1.56% ▲ 0.00% Dec 31, 2025
10 State Street Corp 2.89M 1.42% ▲ 2.21% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $4.93B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $5.64B
EBITDA: $-486.75M
Book Value: $4.85
Earnings/Share: $-2.67
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -41.33%
ROE (TTM): -69.35%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-03-31 11.16x 0.00x 0.09x N/A 0.00x
2024-03-31 13.70x 0.00x 0.07x -5.42x 0.00x
2023-03-31 9.34x 0.00x 0.11x -16.69x -0.01x
2022-03-31 11.52x 0.00x 0.09x -238.22x -0.01x
2021-03-31 21.79x 0.00x 0.05x N/A -0.01x
2020-03-31 7.12x 0.03x 0.14x -95.48x -0.05x
2019-03-31 0.85x 12.22x 0.94x N/A -10.56x
2018-03-31 0.07x 0.00x 14.23x N/A N/A

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Jan 21, 2026 Jay S Stout N/A Sale 1.98K $26.03 $51.46K
Jan 07, 2026 Jay S Stout N/A Sale 1.20K $26.53 $31.92K
Dec 18, 2025 Tuyl Christopher Van N/A Sale 10.81K $26.91 $290.98K
Dec 01, 2025 Andrew J Fromkin N/A Sale 22.25K $23.25 $517.29K
Dec 01, 2025 Douglas J Hughes N/A Sale 15.00K $23.24 $348.60K
Nov 20, 2025 Melanie Gloria N/A Sale 12.63K $23.62 $298.23K
Oct 22, 2025 Jay S Stout N/A Sale 2.52K $19.03 $47.96K
Oct 22, 2025 Michael Geffner N/A Sale 2.60K $19.03 $49.38K
Oct 08, 2025 Jay S Stout N/A Sale 1.59K $16.30 $25.84K
Oct 08, 2025 Michael Geffner N/A Sale 1.27K $16.30 $20.73K
Jul 23, 2025 Jay S Stout N/A Sale 2.81K $18.15 $50.91K
Jul 23, 2025 Michael Geffner N/A Sale 2.39K $18.15 $43.29K
Jul 09, 2025 Jay S Stout N/A Sale 1.52K $17.24 $26.19K
Jul 09, 2025 Michael Geffner N/A Sale 1.16K $17.24 $20.00K
Apr 23, 2025 Jay S Stout N/A Sale 1.93K $14.79 $28.47K
Apr 23, 2025 Michael Geffner N/A Sale 2.35K $14.79 $34.74K
Apr 16, 2025 Eva Renee Barnett N/A Sale 2.99K $14.89 $44.57K
Apr 16, 2025 Peter Salzmann N/A Sale 8.32K $14.89 $123.90K
Apr 09, 2025 Peter Salzmann N/A Sale 28.09K $12.99 $364.94K
Mar 07, 2025 Andrew J Fromkin N/A Sale 8.00K $19.60 $156.80K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMVT.US!